Glenview Trust’s Zimmer Biomet ZBH Stock Holding History

Glenview Trust’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$421K	Sell	4,888 -6	-0.1%	-$526	0.01%	398
2026 Q1	$443K	Buy	4,894 +941	+24%	+$86.3K	0.01%	378
2025 Q4	$355K	Sell	3,953 -1,380	-26%	-$131K	0.01%	408
2025 Q3	$525K	Sell	5,333 -373	-7%	-$37K	0.01%	369
2025 Q2	$520K	Buy	5,706 +74	+1%	+$7.16K	0.01%	368
2025 Q1	$637K	Buy	5,632 +1,581	+39%	+$169K	0.01%	325
2024 Q4	$428K	Sell	4,051 -868	-18%	-$93.1K	0.01%	373
2024 Q3	$531K	Buy	4,919 +15	+0.3%	+$1.64K	0.01%	350
2024 Q2	$532K	Buy	4,904 +450	+10%	+$53K	0.01%	340
2024 Q1	$588K	Buy	4,454 +316	+8%	+$39.5K	0.01%	324
2023 Q4	$504K	Sell	4,138 -1,426	-26%	-$159K	0.01%	336
2023 Q3	$624K	Hold	5,564	–	–	0.02%	283
2023 Q2	$810K	Buy	5,564 +84	+2%	+$11.4K	0.02%	257
2023 Q1	$708K	Sell	5,480 -94	-2%	-$11.8K	0.02%	264
2022 Q4	$711K	Buy	5,574 +172	+3%	+$20K	0.02%	263
2022 Q3	$564K	Buy	5,402 +130	+2%	+$14.3K	0.02%	258
2022 Q2	$554K	Sell	5,272 -89	-2%	-$10.6K	0.02%	265
2022 Q1	$686K	Buy	5,361 +352	+7%	+$42.4K	0.02%	251
2021 Q4	$618K	Buy	5,009 +399	+9%	+$52.2K	0.02%	258
2021 Q3	$655K	Buy	4,610 +409	+10%	+$60.2K	0.03%	237
2021 Q2	$656K	Hold	4,201	–	–	0.03%	227
2021 Q1	$653K	Buy	4,201 +585	+16%	+$90.6K	0.03%	220
2020 Q4	$541K	Hold	3,616	–	–	0.03%	228
2020 Q3	$478K	Hold	3,616	–	–	0.02%	239
2020 Q2	$419K	Sell	3,616 -294	-8%	-$33.9K	0.02%	244
2020 Q1	$384K	Hold	3,910	–	–	0.03%	236
2019 Q4	$569K	Buy	3,910 +124	+3%	+$17.1K	0.03%	222
2019 Q3	$505K	Sell	3,786 -165	-4%	-$21.3K	0.03%	237
2019 Q2	$452K	Hold	3,951	–	–	0.03%	243
2019 Q1	$490K	Sell	3,951 -165	-4%	-$18.8K	0.03%	235
2018 Q4	$415K	Hold	4,116	–	–	0.03%	241
2018 Q3	$525K	Hold	4,116	–	–	0.03%	227
2018 Q2	$445K	Hold	4,116	–	–	0.03%	221
2018 Q1	$436K	Sell	4,116 -309	-7%	-$35.9K	0.03%	245
2017 Q4	$518K	Buy	4,425 +284	+7%	+$32.1K	0.04%	236
2017 Q3	$470K	Sell	4,141 -481	-10%	-$55.5K	0.03%	236
2017 Q2	$576K	Sell	4,622 -41	-0.9%	-$4.86K	0.04%	210
2017 Q1	$553K	Hold	4,663	–	–	0.04%	214
2016 Q4	$468K	Buy	+4,663	New	+$500K	0.04%	224
2015 Q4	$456K	Buy	+4,581	New	+$448K	0.05%	184
2014 Q4	$504K	Buy	+4,581	New	+$483K	0.05%	162
2013 Q4	$552K	Buy	+6,093	New	+$527K	0.06%	132

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Glenview Trust's ZBH Position: Q2 2026 in Review

Glenview Trust reduced its Zimmer Biomet (ZBH) stake by 0.12% in Q2 2026, selling an estimated $526 and leaving 4,888 shares worth $421K. The position accounts for 0.01% of the portfolio, ranked #398.

Glenview Trust first reported a position in ZBH in Q4 2013 and has held it in 42 quarters since. The position peaked at $810K in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Glenview Trust held 4,888 shares of Zimmer Biomet worth $421K as of Q2 2026.
Glenview Trust sold 6 Zimmer Biomet shares in Q2 2026, an estimated $526.
Zimmer Biomet made up 0.01% of Glenview Trust's portfolio in Q2 2026, its #398 holding.
Glenview Trust first reported a position in Zimmer Biomet in Q4 2013 and has held it in 42 quarters since.
Glenview Trust's Zimmer Biomet position peaked at $810K in Q2 2023.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.